ABIONYX Pharma
ABNX | PA
Overview
Corporate Details
- ISIN(s):
- FR0012616852 (+1 more)
- LEI:
- 969500785J7VIC5YPC96
- Country:
- France
- Address:
- 33 AVENUE GEORGES POMPIDOU, 31130 BALMA
- Website:
- https://abionyx.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones Thanks to its partners in research, medicine, its bioproduct suppliers and its shareholders, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-06 18:15 |
AGM Report
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 273.9 KB | |
| 2025-06-03 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 198.3 KB | |
| 2025-06-03 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 218.9 KB | |
| 2025-05-28 18:00 |
Quarterly Report
Quarterly financial reporting / First quarter financial report
|
English | 315.4 KB | |
| 2025-05-28 18:00 |
Quarterly Report
Information financière trimestrielle / Information financière du premier trimes…
|
French | 282.2 KB | |
| 2025-05-06 21:33 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 220.6 KB | |
| 2025-05-06 21:33 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 201.5 KB | |
| 2025-04-03 20:16 |
Declaration of Voting Results & Voting Rights Announcements
Total number of voting rights and capital / Information on the total number of …
|
English | 220.6 KB | |
| 2025-04-03 20:16 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 201.4 KB | |
| 2025-03-21 07:30 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 253.8 KB | |
| 2025-03-21 07:30 |
Regulatory News Service
Inside Information / Other news releases
|
English | 221.7 KB | |
| 2025-03-17 18:00 |
Report Publication Announcement
Annual financial and audit reports / Terms of availability of the annual financ…
|
English | 199.5 KB | |
| 2025-03-17 18:00 |
Regulatory News Service
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
|
French | 193.4 KB | |
| 2025-03-05 07:30 |
Earnings Release
ABIONYX Pharma annonce ses résultats annuels 2024
|
French | 316.1 KB | |
| 2025-03-05 07:30 |
Earnings Release
ABIONYX Pharma Announces Its 2024 Full-Year Results
|
English | 232.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-02-28 | N/A | Other | Buy | 53,913 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Can-Fite BioPharma Ltd. | Israel | CANF | |
|
Cantargia | Sweden | CANTA | |
|
Captor Therapeutics S.A. | Poland | CTX | |
|
Carbiotix AB | Sweden | CRBX | |
|
Cellectis | France | ALCLS | |
|
CELLULAR GOODS PLC | United Kingdom | CBX | |
|
Celyad Oncology SA | Belgium | CYAD | |
|
Cereno Scientific AB | Sweden | CRNO | |
|
Cessatech A/S | Denmark | CESSA | |
|
CHOSA Oncology AB | Sweden | CHOSA |